%PDF-1.7 % 13 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20250610071005+02'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 14 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 5 0 R ] /PZ 1 >> endobj 14 0 obj <> stream xZr6}Wc2c377q2$Qڇ$0`h]LŲcP^ȧ,7ttJxMG)<@{{t'o 7or퀛(p6@5o>#:'<᥄'wbW՗W߼k;w7lT$-.?[Ҋӑ aEp)|| 3LXpxS,{gS@  ~rΞnq"ϟc?lp?> *8R2SWR~`K-ƨT R D*u)&FXRjLA dR=Hi8Bah7^unsus< m[g8lEv[AA臃;{@+n>Ggp+C/<榝A "7-)A(zv̟8B@!1lgpV4\O]*E?-XB a % ȭL*!psMjx[K+DfM /j36 [fxmH.5D ^H_.jE&KȂ{5)L*ƓsBJ["> /Annots [ 6 0 R ] /PZ 1 >> endobj 16 0 obj <> stream x[rF}W㦊bxhWdYd}eũTk0X*ߴ9=3Hb;x rQ&0h?E+~o9G8s}8󳂎~p Ba1}oN遥w^~{|~W_>[hx`/ |>MNJy)ϕ)y;*XiU@&ls*[8QlʁWqa[,w@?81nFp2o'IP&]#!c͞&CnZ b ǧW> *mk:7ve饸e^ĥLZ-^Sm\v"lAtZrMR8!*ۉ,ֵu UPfd:P@4˜bZ;$D 6GocRM3K 0@5pCQG~%1 83]8qB!㿴'kUR QLD*9!;;l+)RDZZcbqn[;l3̀\i/]iy"PqO=DxL.nBKUl2J|H)l=ٻB/*jH.O>&"Tldž"Mp(N֐pLBq !8X5;", ¾ 2dD@:lC$NyQUXt!WN'Z?ؐL,y>Bda2fAgFNTm9ɭipCHHdZ+drnRr?pH/ɺ#iN+/5HJ^ Z 8$-L8J(pYck=uQyIwa'2wN-`b/z͚\8 ^հ߅XuQ|&Ep*~rzttyPf#v-N7`B(<>ZJ9D/f?ar u.r9p7;~khpotWɓհ蟓U?hR("tȫ`.PxǗxӝ;Qx|I-X+r%\u:_ \r{֛%jg2ܧJi]d! JnBN š}d4 l8K 5f_ s@Ã8:M>}p>nͥ  =F7]>ņo9ˍ|P)t&.։ `Mf-Gq ~CfJK)m+*To=<ԩNʼnŐ=&w{)n\ƕ7³.mL6gnuր$9i*ŸP~ǚ/~8GORymT%p'll[.ciB5@4#:$b\ՂQ%kuD&szu!XsVD%lxIi+])NILg:}Ud D˼wY x`aLe/:jpm+4Bnk}b'3$ȯѤMv``l өXXևX{ pXEsffKVӴQqt$ 4չ5F˖#,&8M,\kשT'F}L:iN7];sS ]w,alF df/d(̤SԝUi>p]$Ig[ fz[Rf_:ox6,t4o[wB mOǜmn%${pH8r̀ypҩchMGЌ-nEfN(@ Aϲ[=7*SzZPiU=UP? _S(] endstream endobj 17 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20250610071005+02'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 18 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 7 0 R 8 0 R ] /PZ 1 >> endobj 18 0 obj <> stream xv8<]g|(8|&0 `7Z[ ܐ'gݬJۤ`Jz86-׽0!޼MaϚtD~< :kO`|+KX=1^=_"q DAm6]&M+3>z /nX?OrKeyۜh[a0 ^ 0Ha4qo~ /?KWcف(3nXoEe2tҦYyZz3^BoG *ԇ8T599<Ō\ c4Uuc)DF /_4Ejs( Oj㌄AڌʥΏWϩN3OSXi^j碝6, DSa&2*B_}M˖|JCɚcki'Is,?)6R*!X8mY\5Q%i3%eb0-DkC!Jh颒, /QyT[Ph-Ԧt2N봶k_H?-$peGYԅWZTha")!qpₐTLuйp57EP-bA֌v&, '&͉Q=w.㯏0WV-(QO/lT!gܧRN^}wmtc^Қ=jr1tpOW7n 2uxKDvFeln,:w f~%W4K_$i:` UWەȿ'ӿr~` JNxooXtT$eٕ 3;XDȿBKn!({{kتclY5~Ek]?n@'wd(ߒݿUJ#aP J}l$5HGՊe&R5 T1p1}%MG endstream endobj 19 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20250610071005+02'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 20 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 9 0 R 10 0 R 11 0 R 12 0 R ] /PZ 1 >> endobj 20 0 obj <> stream xYKsGW1̣3GqPUAeHA6">L6~Ur򩧧_wJcܩ)޻oqs7H2qw >wNvUͅqso~Z YG{}=<ܓ{<îCݝ>':p۬`ر,(:)KMvO=\8୛<+j<α;^6c{]*K$:q3z9ߟJN#zeރr"^Ck7E)"6k h>?WŻ'8?#_MNStU7<.DJ5^>-tv^'xM*`JdMSwޠ5ITSΪG3z{Eqӡ?`Gq{S:wjp[l[t9XIcZ^NQ?pm[vJSk?>9$Uų6PB %70<hE pɥ9Ze9Ǫ 3$QfQS^)Ȕ,qb1M>P6* .lԬH9DJ ,@f0))  Iss$1 ԧB ΈĤ 'UGӛ#LUV355XA)!X[)L"dp`A&#T"j`TLA̅R O"U6d lF-!ƞB\Pc[,PAsRS {`AWHAS Hr,($b[/Aik=\,"b #0̒S 0vȾU*9[Ǜ edQ2hZ-p'l[Q(썉LʲgiVQċ,%@DާPhSSEQU<`(bpiը`T|,V$OM0*>ԈE{_6_hn,D/ }w?d l/9FA!!F_"iz!-RsnLŔ6RL@JJVL=BTݠ2 hm ZbOc_CqQkWs]*cr@оkPL:|* ZK@aq>eS0?xb)ƍ )HTMЀĄdVݲ$uhH NF@*Ļ!Z6KK'0Dѷ4+$/1ڐ:s=1(VΣ8RYhXRc~f{Ԍ-BV kq[EKn]|S| {ߓЖnzwto0vk,OG鞛OvXYlIcWI7~¢"좿Y嗵+(L[1ظc{hLy<{nTqo~:==Nfwk_M endstream endobj 1 0 obj << /Type /Pages /Kids [ 13 0 R 15 0 R 17 0 R 19 0 R ] /Count 4 >> endobj 3 0 obj <> endobj 4 0 obj <> endobj 21 0 obj <> /Resources <> /Font <> /ExtGState <> /ProcSet [/PDF /Text /ImageB /ImageC /ImageI ] >> /Filter /FlateDecode /Length 848 >> stream xWmO0^c$H (똆AIC|J(ՠemIªل׹Gdw7>9<GkDžaW$<"H2|R(29:9$^-e>..y.Gd:|VCd` ')ɮB(TEҒ %% E֙ J,$BDO&D>MH0-6=C.h&CfR\ X+b :Nic*k+ p.}&xs|"8 n,v )W-6o=߸hNftK:M[ۀr!e\KeAky$RP<⺍pxup8>H  M{qI3_w,縲eGfNՑmna.hȓjYU,b\2OuyZ6#sC͚3gkriӲ ly#4]kDfu |w*lm O镸080iIsӵһ%7/i\XJ.̚5K5jM9aq'wqh%Q*i gyQ(p]5'CԫkSuRCln_*9{.+|FAqp-Pg*O hsRՎSJ&`1U$GBHB-K5NюG~?Rh#%SkC3a-r"7αը $O+ o endstream endobj 28 0 obj <> /Resources <> /Font <> /ProcSet [/PDF /Text /ImageB /ImageC /ImageI ] >> /Filter /FlateDecode /Length 220 >> stream x]M0EԅIтUqEڅ̿7.:Ãۼ{?bb_"YiFgTT&IF |Sk=(PB{U!Z]?s{7mCwoTbV DH)iRHK 4 A&J0;*UaVj&T]Y-v|OɄzUx5>w I endstream endobj 27 0 obj <> endobj 26 0 obj <> endobj 33 0 obj [250 0 0 0 0 0 0 0 0 0 0 564 0 333 250 0 500 500 500 500 500 0 500 500 500 500 0 0 0 0 0 0 921 0 0 0 722 611 556 722 722 0 0 0 0 889 0 0 556 0 667 556 0 0 0 0 0 0 611 0 0 0 0 0 0 444 500 444 500 444 0 0 500 278 0 500 278 778 500 500 500 0 333 389 278 500 500 722 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 ] endobj 32 0 obj <> endobj 25 0 obj <> stream x  Om7^ Oa endstream endobj 34 0 obj <> stream x nH@o endstream endobj 24 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( m{HV*ڝ 2֍sD$;k]-j** jmZކ6PϷXkW״y,H$c``qW_Wx4pYd]pI"TnϿD1Vn57N]KEgi70n63# :*Zޡyڬ4:Гp vFJ{m龖u_!Fxgnz犯6cjP <,08 - bE^Z7wmfON4%pJ<H%f\OnMowC۾ǽG6<_jx0&s7kvߙokVkY~nn䲺k[X0eXuV ~ILA+G#I(D8qc=>J'}77h/Uknmkkb 0yHw/6@2nY*pMzU3%ėڌʻe/9I>OS_zwqlTM$1!vzڥʺy22eg{/㱷EgX\?lJ8cU4I #|K3G|T{ƿZZunTpCp*H1S0I\։r,f ěsR>hJq:Z+ -kP[ '̀ 8B޻F9fB<8D>hݴ5NDn+E說uZk6(95Gyd , 9kVh驖cdex[O!U'}me}SZwТ5;hMΌR ϲp"5iOW|LS d {u*mMow4Z4baIXcnf>L«hIc}h4lHg'R*uٽ~ocVʳէ{~`HdS!r+3Cm{TWx24VgQccm{u"=ŰNy'&U Eٻ~-lNr֨WIѥ;W>z+YT3*RWi4׫8ȗĚ̐Zrо ~EO XOԒM]mllͭ[#l%IMIikV"v''EPG9@``n^s _vbWe[3ImjK}\iY >}Ac1GI]VkזׂMKsn!rK2@ێ=xku{MJ8EDR.v)_KIkz>M +mv_k2sRj#$d>Zl;5i!)70 :^v?Rnm{ZnkYWzXiqVj a idzI cK>n[}鹭Eb6q6wXy۰Mqjk Vy4Qotdtf߯QRSmZmB;iI $l3gVf]&k|QlaB$&pL#oN55&!b+rVvپz]ڽivI:@$Yv&F'>m͵ 3D[pe=OqIњWȨi\iQX"v:k"H)2Hb9$rN3[3(;HUY^љ] ʇ O|k%ՐVfrkzxшLn\]:Jq|JǶkRwooYRm,ѵӱYWz\bIYؑ'}(n^EEDzM"5u}f7/vkX$*8!YbEi" H򤌌3\'m9CqqJֲ: @KgɜL*A}gK$խS/+mEaEjw -ӬfY< ~5$!?ɫG 0xXemH=y*^KFW+]WA Xrڨktk@¼eeی;g5O]M絷ZD2m1|prQ}]DTӌ%%{{Ym(eB$18 d>i:v N2FGҥQ_r劥z/=4\ې&8Nx8Ts~V=Z X'g"YVwqw6q#$ӄ#%0U8KHi$7WSЩȧU ZhQRYv~RiS ((((m6d պᅾ[UM#zͽЬon>$78ǝ6#܎k G^5ZsUZzYjrik$XrIj[)R?}馕mm43|\ ێgH{ JqӗFk[]-4Iq)J,iAD['ciHF:VZ<Li>sBz'}֤pK{ ۩3B<EŜR*>H?J̩ay'rXP 's29cM.+j)CE*B VgY\fY.z e(FjW%# tΜYZs>߱IgԵkm."ٖ7qy$lgzun>%u?JjI&:LԖ:=: $qi =ңBm N[Wߦ~E=t>?Q7H,ඞh.4$䁏CYzT6O'$cuW3~V,ZSQ+͓&#.mjDL$hqQ (I_ZnSGMHᷓE2X\m3 vWF4 0[c,=֧mt- Yy5B TaIۖ6׽yEU Zb}?nTvpXbR]I䜚59.NJ0{rvZ5Oyu wmm<=XγfUıLoeDIp9'$ ~bvh`^Q\n3j:Ykd$h"0x侖ad̛Fߘ`Zzٻ<v,=:E: !a,,]ds9j4Vvc,=iJ[J[e_M\vAjϚ9%>- KwJܗGQ[JnLr2@ 7\ӊ^).P{sIavzƕi-vtأO k-od@_rpGo?Kb{#vDbz?[}&M37 i<$t9׭ZAIK=TZוOVe;l?ʹ^?*J`EKifXҪkOՉʭ2_7o+a})!7&t2U=>-[E5w<7QGcVz=iX:i t'ҫ/rY.+ 1ӌө7oLε |$m[׺h&$wX6+ $tVN{w 5HaҭW;嶇ly (((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( endstream endobj 23 0 obj <> stream x  Om783  endstream endobj 35 0 obj <> stream x nH@paX endstream endobj 22 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222bb" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( *kZ= )՘W5mZx?sS)(rbzz.-+E_|dF>g?qZP ]3N'K:?ƸT/.\$s1c 'j9W᭏=Mrķsݓ@aGrZ}{R}NՋHf?^d!,.@#VnZ)BJPG i6ב9O?0H\kǝףG1>X;} ExM_@eZ}H2Bo_U a1Jr˺-aUL cZݫ L7YSG/k?oo\jSѫV]֙宙>bx.2)YWN/XޑxVRr{W\֡p~Z7gS憌#ˌ5JOkT{Y$9$5b'JAI a}%hT(((kH0zVBEY[RI(GJ?zӉ[?kFniE?D;o l_DP^Xž "Lh?g |{עW|mIW̗ɏL,WQCz-Wv\@He@єRWWTV.⤂( ( ( ( ( ( ( ( ( ( ( ( ( ziSs('*:e>#j\!eG9_Ɍ-/S#N_GxA'4?2+><(niv%Lp?aG2_Iѽ~kNe>XՂ (((((F`Y I=c9ũՍ0}E $=M ||?hjz#59½OC+oEQEQEQEQEQEQEQEQEQEQEQEQEW;65(jnm;<>/sW~ʯT4bXZJy UEYk (;QEIaEPEPYֳmX5,x0yvmwĶZDH[>X>Uծ{ƹ|EQPz^*ϚzG<\7.7y^V/ԯe}Hr}~SZs;p } J*:ӟ4lNHcfF q*<%s] o,z'eд ( ( ( ( ( ( ( ( ( ( ( ( ( +h[TělOSa )CV &8ş#im ҺkIT׆>+)lݶ~^ s_QJT~΢7ȩk>l]GȮϟekYx^=+Spߊ\5l5*F\u|+)[˧{%{|=?Z5o^݆1i~r?5Q]r4ڻUfԜ?t=*ߔ<3cVoĒkN_Wr>ʍ?g+P(((((((((((((߄a~*^Ù-e?އ?_5/e(H+ωOMUM^%t ;{cb3 cuV`k8 s\j=KtquV s^d|':d4sYP:մg:M訄y+E3Q@rLPw܁ޕ#Iifu˫梹k j%#a[a{vX5 <]/.Ѱ(vO},: q̧0cw>g`p IQ^QQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@g..-55\%ʯwG^ Yٵ;V's[ӭ}]U-5;Gr`:'KG9k!W]򥾣Z1_k|CJ}9[ϗo?לj^n4學W/#{l[%вEK]Ha*AsΖQ^ZNƿsҎq,: oY杦sZ/~u2IO~?.e_XsX?k*?2G}%pƹ&=K!..;QGonZ/ i4(|<կ'Ov/`OW (((((((((((((((<2"V`)\>|v08 Z( ( ( +7YcSFڇc65Mťvnɕ/4;P+_Nc,b=MNQى/ts)QПkRú.A,`aѣE?MD : nލPcϢ5-AAEPExK֧O`-a9?iKa9$osN(0(((((((((((z+qBԃTs\q [3kG|?wwXEu2դB)Mj὜6R~j6dTFLr@ bWW9]،EJxYۡÇNxxt8+z$oR>V>VNj|=i1}j$|$|t7WDx%y"E:9/ \ PI4A({U~ Z;u՛!/+s%K1 @A#k>X;CUB]TU88s-wrpq~j ;ƻnŧ H\4`N΀XzYTs)ՔtI)bH5K ,RFQ2l{&o~,fl;|Aj~)XeزE PsʁV<mw[iOl#dP ޠnNsZBp7i}pI$Js6qnD1ykZ<:ڹcԓ'T&*mNYQT18J^)jkoEe [xZfm,Y@Ԍ m:/Ŧ<.مP;zV?~6ݶy ޹U9B&TeOI껛V 4jTFN `Ӯr+GP%_VFBI( Z|%]Z-C;bn8 GB+v-A𦩨뗷r2z8JrSV۶2ԋ$~д}14Ni^#K! D, O@NzWH%Kkw* B2O%{w?ABӯ{i Ȇ(@3d凄\ݕLqz>-6y jp>?|aP>?9j? C|XehmQ (8C\F|µ 'kt♜k OkhS bSyp0Y[\!<yj3EqO $R(du9 Ba"։.co2g夑8?s׍ëw17Ṿ; Q\:}$_;{=SOGXUp\*%7?g۰sy9yF hYj ۙrT𮓩hRi_b8cpiZ\U4JmEp_ u+ Kor'8LI1]aV7ڕER kQEQEQEQEQEQEQEQEQEUMVO+G?)V覝Տ#m  hVZTo ?ٮX>94 iW1bOy'yEt Tu9u 6un/ ?FrDeQ`~xk^ \v-kG"NZퟝLWQJ8:nאU쒷y^d)Ze1ijd`u?zYC/&wnF1ֽrj5ǚM᫏"lB֪$9YK=2 *ޑ"lb4J-V%)lXÌ޽Onkӄgc$KymhfkuRn3[KjIoXԱ?^WUE%^ܖ_ N%c˼]!-ge2X0EzMImnCDd{ EMJQV—$/U) %qm"HAg{_ĈUڊJ 5%r6]5a)4$UM9 ៥kMxWubh0?,~:~5TVZӎ3ZK[_|AYk%ڬA OL~|5YP1cBgz 3s)+n ?+'ʟٞmc ,\ӱ3@{ d+ːJёé=qz:)iE-WQf y`JE;!4c ~c[L?= $v$7>#^&Yk%X,O$U > endobj 37 0 obj [250 ] endobj 36 0 obj <> endobj 30 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( m{HV*ڝ 2֍sD$;k]-j** jmZކ6PϷXkW״y,H$c``qW_Wx4pYd]pI"TnϿD1Vn57N]KEgi70n63# :*Zޡyڬ4:Гp vFJ{m龖u_!Fxgnz犯6cjP <,08 - bE^Z7wmfON4%pJ<H%f\OnMowC۾ǽG6<_jx0&s7kvߙokVkY~nn䲺k[X0eXuV ~ILA+G#I(D8qc=>J'}77h/Uknmkkb 0yHw/6@2nY*pMzU3%ėڌʻe/9I>OS_zwqlTM$1!vzڥʺy22eg{/㱷EgX\?lJ8cU4I #|K3G|T{ƿZZunTpCp*H1S0I\։r,f ěsR>hJq:Z+ -kP[ '̀ 8B޻F9fB<8D>hݴ5NDn+E說uZk6(95Gyd , 9kVh驖cdex[O!U'}me}SZwТ5;hMΌR ϲp"5iOW|LS d {u*mMow4Z4baIXcnf>L«hIc}h4lHg'R*uٽ~ocVʳէ{~`HdS!r+3Cm{TWx24VgQccm{u"=ŰNy'&U Eٻ~-lNr֨WIѥ;W>z+YT3*RWi4׫8ȗĚ̐Zrо ~EO XOԒM]mllͭ[#l%IMIikV"v''EPG9@``n^s _vbWe[3ImjK}\iY >}Ac1GI]VkזׂMKsn!rK2@ێ=xku{MJ8EDR.v)_KIkz>M +mv_k2sRj#$d>Zl;5i!)70 :^v?Rnm{ZnkYWzXiqVj a idzI cK>n[}鹭Eb6q6wXy۰Mqjk Vy4Qotdtf߯QRSmZmB;iI $l3gVf]&k|QlaB$&pL#oN55&!b+rVvپz]ڽivI:@$Yv&F'>m͵ 3D[pe=OqIњWȨi\iQX"v:k"H)2Hb9$rN3[3(;HUY^љ] ʇ O|k%ՐVfrkzxшLn\]:Jq|JǶkRwooYRm,ѵӱYWz\bIYؑ'}(n^EEDzM"5u}f7/vkX$*8!YbEi" H򤌌3\'m9CqqJֲ: @KgɜL*A}gK$խS/+mEaEjw -ӬfY< ~5$!?ɫG 0xXemH=y*^KFW+]WA Xrڨktk@¼eeی;g5O]M絷ZD2m1|prQ}]DTӌ%%{{Ym(eB$18 d>i:v N2FGҥQ_r劥z/=4\ې&8Nx8Ts~V=Z X'g"YVwqw6q#$ӄ#%0U8KHi$7WSЩȧU ZhQRYv~RiS ((((m6d պᅾ[UM#zͽЬon>$78ǝ6#܎k G^5ZsUZzYjrik$XrIj[)R?}馕mm43|\ ێgH{ JqӗFk[]-4Iq)J,iAD['ciHF:VZ<Li>sBz'}֤pK{ ۩3B<EŜR*>H?J̩ay'rXP 's29cM.+j)CE*B VgY\fY.z e(FjW%# tΜYZs>߱IgԵkm."ٖ7qy$lgzun>%u?JjI&:LԖ:=: $qi =ңBm N[Wߦ~E=t>?Q7H,ඞh.4$䁏CYzT6O'$cuW3~V,ZSQ+͓&#.mjDL$hqQ (I_ZnSGMHᷓE2X\m3 vWF4 0[c,=֧mt- Yy5B TaIۖ6׽yEU Zb}?nTvpXbR]I䜚59.NJ0{rvZ5Oyu wmm<=XγfUıLoeDIp9'$ ~bvh`^Q\n3j:Ykd$h"0x侖ad̛Fߘ`Zzٻ<v,=:E: !a,,]ds9j4Vvc,=iJ[J[e_M\vAjϚ9%>- KwJܗGQ[JnLr2@ 7\ӊ^).P{sIavzƕi-vtأO k-od@_rpGo?Kb{#vDbz?[}&M37 i<$t9׭ZAIK=TZוOVe;l?ʹ^?*J`EKifXҪkOՉʭ2_7o+a})!7&t2U=>-[E5w<7QGcVz=iX:i t'ҫ/rY.+ 1ӌө7oLε |$m[׺h&$wX6+ $tVN{w 5HaҭW;嶇ly (((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( endstream endobj 29 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222bb" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( *kZ= )՘W5mZx?sS)(rbzz.-+E_|dF>g?qZP ]3N'K:?ƸT/.\$s1c 'j9W᭏=Mrķsݓ@aGrZ}{R}NՋHf?^d!,.@#VnZ)BJPG i6ב9O?0H\kǝףG1>X;} ExM_@eZ}H2Bo_U a1Jr˺-aUL cZݫ L7YSG/k?oo\jSѫV]֙宙>bx.2)YWN/XޑxVRr{W\֡p~Z7gS憌#ˌ5JOkT{Y$9$5b'JAI a}%hT(((kH0zVBEY[RI(GJ?zӉ[?kFniE?D;o l_DP^Xž "Lh?g |{עW|mIW̗ɏL,WQCz-Wv\@He@єRWWTV.⤂( ( ( ( ( ( ( ( ( ( ( ( ( ziSs('*:e>#j\!eG9_Ɍ-/S#N_GxA'4?2+><(niv%Lp?aG2_Iѽ~kNe>XՂ (((((F`Y I=c9ũՍ0}E $=M ||?hjz#59½OC+oEQEQEQEQEQEQEQEQEQEQEQEQEW;65(jnm;<>/sW~ʯT4bXZJy UEYk (;QEIaEPEPYֳmX5,x0yvmwĶZDH[>X>Uծ{ƹ|EQPz^*ϚzG<\7.7y^V/ԯe}Hr}~SZs;p } J*:ӟ4lNHcfF q*<%s] o,z'eд ( ( ( ( ( ( ( ( ( ( ( ( ( +h[TělOSa )CV &8ş#im ҺkIT׆>+)lݶ~^ s_QJT~΢7ȩk>l]GȮϟekYx^=+Spߊ\5l5*F\u|+)[˧{%{|=?Z5o^݆1i~r?5Q]r4ڻUfԜ?t=*ߔ<3cVoĒkN_Wr>ʍ?g+P(((((((((((((߄a~*^Ù-e?އ?_5/e(H+ωOMUM^%t ;{cb3 cuV`k8 s\j=KtquV s^d|':d4sYP:մg:M訄y+E3Q@rLPw܁ޕ#Iifu˫梹k j%#a[a{vX5 <]/.Ѱ(vO},: q̧0cw>g`p IQ^QQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@g..-55\%ʯwG^ Yٵ;V's[ӭ}]U-5;Gr`:'KG9k!W]򥾣Z1_k|CJ}9[ϗo?לj^n4學W/#{l[%вEK]Ha*AsΖQ^ZNƿsҎq,: oY杦sZ/~u2IO~?.e_XsX?k*?2G}%pƹ&=K!..;QGonZ/ i4(|<կ'Ov/`OW (((((((((((((((<2"V`)\>|v08 Z( ( ( +7YcSFڇc65Mťvnɕ/4;P+_Nc,b=MNQى/ts)QПkRú.A,`aѣE?MD : nލPcϢ5-AAEPExK֧O`-a9?iKa9$osN(0(((((((((((z+qBԃTs\q [3kG|?wwXEu2դB)Mj὜6R~j6dTFLr@ bWW9]،EJxYۡÇNxxt8+z$oR>V>VNj|=i1}j$|$|t7WDx%y"E:9/ \ PI4A({U~ Z;u՛!/+s%K1 @A#k>X;CUB]TU88s-wrpq~j ;ƻnŧ H\4`N΀XzYTs)ՔtI)bH5K ,RFQ2l{&o~,fl;|Aj~)XeزE PsʁV<mw[iOl#dP ޠnNsZBp7i}pI$Js6qnD1ykZ<:ڹcԓ'T&*mNYQT18J^)jkoEe [xZfm,Y@Ԍ m:/Ŧ<.مP;zV?~6ݶy ޹U9B&TeOI껛V 4jTFN `Ӯr+GP%_VFBI( Z|%]Z-C;bn8 GB+v-A𦩨뗷r2z8JrSV۶2ԋ$~д}14Ni^#K! D, O@NzWH%Kkw* B2O%{w?ABӯ{i Ȇ(@3d凄\ݕLqz>-6y jp>?|aP>?9j? C|XehmQ (8C\F|µ 'kt♜k OkhS bSyp0Y[\!<yj3EqO $R(du9 Ba"։.co2g夑8?s׍ëw17Ṿ; Q\:}$_;{=SOGXUp\*%7?g۰sy9yF hYj ۙrT𮓩hRi_b8cpiZ\U4JmEp_ u+ Kor'8LI1]aV7ڕER kQEQEQEQEQEQEQEQEQEUMVO+G?)V覝Տ#m  hVZTo ?ٮX>94 iW1bOy'yEt Tu9u 6un/ ?FrDeQ`~xk^ \v-kG"NZퟝLWQJ8:nאU쒷y^d)Ze1ijd`u?zYC/&wnF1ֽrj5ǚM᫏"lB֪$9YK=2 *ޑ"lb4J-V%)lXÌ޽Onkӄgc$KymhfkuRn3[KjIoXԱ?^WUE%^ܖ_ N%c˼]!-ge2X0EzMImnCDd{ EMJQV—$/U) %qm"HAg{_ĈUڊJ 5%r6]5a)4$UM9 ៥kMxWubh0?,~:~5TVZӎ3ZK[_|AYk%ڬA OL~|5YP1cBgz 3s)+n ?+'ʟٞmc ,\ӱ3@{ d+ːJёé=qz:)iE-WQf y`JE;!4c ~c[L?= $v$7>#^&Yk%X,O$U > /XObject <> >> endobj 5 0 obj <> /H /I>> endobj 6 0 obj <> /H /I>> endobj 7 0 obj <> /H /I>> endobj 8 0 obj <> /H /I>> endobj 9 0 obj <> /H /I>> endobj 10 0 obj <> /H /I>> endobj 11 0 obj <> /H /I>> endobj 12 0 obj <> /H /I>> endobj 38 0 obj << /Title (ENDEAVOUR Lung Cancer Program Forms International Teams to Initiate Four Collaborative Projects Focused on Advancing Patient Care) /Author (Daiichi Sankyo) /Subject (ENDEAVOUR Lung Cancer Program Forms International Teams to Initiate Four Collaborative Projects Focused on Advancing Patient Care) /Creator (TCPDF) /Producer (TCPDF 6.8.2 \(http://www.tcpdf.org\)) /CreationDate (D:20250610071005+02'00') /ModDate (D:20250610071005+02'00') /Trapped /False >> endobj 39 0 obj << /Type /Metadata /Subtype /XML /Length 4917 >> stream application/pdf ENDEAVOUR Lung Cancer Program Forms International Teams to Initiate Four Collaborative Projects Focused on Advancing Patient Care Daiichi Sankyo ENDEAVOUR Lung Cancer Program Forms International Teams to Initiate Four Collaborative Projects Focused on Advancing Patient Care 2025-06-10T07:10:05+02:00 TCPDF 2025-06-10T07:10:05+02:00 2025-06-10T07:10:05+02:00 TCPDF 6.8.2 (http://www.tcpdf.org) uuid:f786b4a4-af35-d4b3-5a54-bb46f82fa0fd uuid:f786b4a4-af35-d4b3-5a54-bb46f82fa0fd http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema internal Adobe PDF Schema InstanceID URI http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 40 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [13 0 R /FitH null] /Metadata 39 0 R >> endobj xref 0 41 0000000000 65535 f 0000009016 00000 n 0000046128 00000 n 0000009097 00000 n 0000009203 00000 n 0000046268 00000 n 0000046524 00000 n 0000046731 00000 n 0000046963 00000 n 0000047207 00000 n 0000047415 00000 n 0000047722 00000 n 0000048121 00000 n 0000000015 00000 n 0000000485 00000 n 0000001791 00000 n 0000002261 00000 n 0000004782 00000 n 0000005258 00000 n 0000006908 00000 n 0000007399 00000 n 0000009314 00000 n 0000020998 00000 n 0000020205 00000 n 0000012535 00000 n 0000011975 00000 n 0000011122 00000 n 0000011066 00000 n 0000010534 00000 n 0000037628 00000 n 0000029958 00000 n 0000029498 00000 n 0000011723 00000 n 0000011308 00000 n 0000012282 00000 n 0000020686 00000 n 0000029706 00000 n 0000029683 00000 n 0000048339 00000 n 0000049144 00000 n 0000054144 00000 n trailer << /Size 41 /Root 40 0 R /Info 38 0 R /ID [ ] >> startxref 54354 %%EOF

ENDEAVOUR Lung Cancer Program Forms International Teams to Initiate Four Collaborative Projects Focused on Advancing Patient Care

• ENDEAVOUR unites 21 promising lung cancer specialists with internationally recognized experts to foster collaboration and improve patient outcomes

• Three-year program aims to promote excellence in research and enhance clinical knowledge

• At launch event in Madrid participants initiated four collaborative research projects which will be developed under expert guidance

 

Madrid – (May 23, 2025) –The ENDEAVOUR lung cancer program, a three-year initiative designed to advance lung cancer research and care by connecting early-career oncologists in Europe with internationally renowned experts in thoracic oncology, has selected 21 participants to form international teams that will initiate four collaborative projects at the kick-off event in Madrid.

The projects to be developed over the next three years under expert guidance address critical unmet needs in lung cancer. The four selected research projects each focus on important challenges: two will investigate treatment resistance mechanisms—one in small cell lung cancer and one in non-small cell lung cancer—with the aim of better understanding the characteristics of these tumors and finding strategies to overcome this resistance. The third project will use artificial intelligence to analyze long-term responders to specific therapies, seeking to identify features that could guide future treatment decisions. The fourth project will concentrate on certain non-small cell lung cancer patients with brain metastases, a group known to have particularly poor prognoses, with the goal of uncovering key characteristics that could support more personalized therapeutic strategies.

“To be chosen among more than 20 projects — all led by passionate professionals asking meaningful questions in lung cancer — is a real honor,” says Dr. Edouard Auclin, Institut Bergonié, France. “Each project brings valuable insights to the field. My project focuses on patients with high inflammation who tend to have poorer outcomes and are often underrepresented in clinical trials. By thinking outside the box, we aim to develop new approaches that could better address their needs and improve their treatment responses. I am truly happy to be part of this program and look forward to what we can accomplish together.”

In addition to Dr. Auclin, the selected project leads are Dr. Marcel Kemper from University Hospital, Germany; Dr. Pedro Rocha from Hospital Vall d’Hebron, Spain; and Dr. Francesca Ogliari from IRCCS Scientific Institute and Hospital San Raffaele, Italy.

 

Fostering Excellence with Patient-Centric Purpose

Lung cancer is the most common cancer and the leading cause of cancer-related deaths worldwide.1 Nearly 2.5 million lung cancer cases were diagnosed globally in 2022.i “Mentoring and fostering the next generation of thoracic oncologists is essential to sustaining scientific innovation and improving patient outcomes,” says Prof. Lizza Hendriks, Associate Professor at Maastricht University Medical Center, Maastricht, The Netherlands and ENDEAVOUR Lung Cancer Program Committee Member. “Through this initiative, participants gain the tools and critical skills needed to become the lung cancer leaders of tomorrow to treat patients with the latest scientific knowledge. I was truly impressed and energized by the outstanding quality of applications received and look forward to the outcomes of the collaborations that will emerge from this program.”

While the participating oncologists deeply exchange about their research and clinical practice within the group, the goal of the program is to improve lung cancer care for patients and have a real-world impact.

“Every advance in cancer care begins with a single idea — and a deep commitment to patients,” says Dr. Michael Zaiac, Head of European Medical Affairs Oncology, Daiichi Sankyo. “At Daiichi Sankyo, we believe that great patient care is fueled by both innovation and experience. ENDEAVOUR brings these elements together by connecting bright, early-career oncologists with seasoned experts, and providing the support needed to turn ideas into impact. We are proud to back a program that fosters scientific excellence while keeping patients at the center of every discovery.”

The ENDEAVOUR lung cancer program is guided by a distinguished steering committee of eight leading experts in thoracic oncology. Together, they are responsible for the independent design of the program, the selection of participants and the scientific mentorship provided throughout.

· Prof. Lizza Hendriks, Maastricht University Medical Centre, Maastricht, The Netherlands

· Prof. Pilar Garrido, Hospital Universitario Ramón y Cajal, Madrid, Spain

· Prof. David Planchard, Institut Gustave Roussy, Villejuif, France

· Prof. António Araújo, Centro Hospitalar Universitário do Porto, Porto, Portugal

· Prof. Frank Griesinger, University Medicine Oldenburg, Pius-Hospital, Oldenburg, Germany

· Prof. Andreas Pircher, Medical University of Innsbruck, Insbruck, Austria

· Prof. Francesco Grossi, University of Insubria, Varese, Italy

· Prof. Natasha Leighl, Princess Margaret Cancer Centre, Toronto, Canada

 

About the ENDEAVOUR Lung Program

The ENDEAVOUR programs are an initiative supported by Daiichi Sankyo, aimed at developing the next generation of oncology top experts across Europe by fostering scientific exchange and clinical practice sharing. Guided by a distinguished steering committee of leading oncology experts, the three-year programs are designed to promote excellence in research and enhance clinical knowledge to drive scientific innovation and improve patient outcomes. Building on the success of the ENDEAVOUR breast cancer program, the ENDEAVOUR lung cancer program will support 21 emerging lung cancer specialists from 2025 to 2027.

About Daiichi Sankyo

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need. For more information, please visit www.daiichi-sankyo.eu.

Media Contacts:

Giedre Petkevice

Daiichi Sankyo

giedre.petkevice@daiichisankyo.com

+49 151 16817651 (mobile)

References

i World Health Organization. International Agency for Research on Cancer. Lung Fact Sheet. Accessed July 2024.